Dashboard
Manage Tickers

SPROSpero Therapeutics, Inc.

Nasdaq sperotherapeutics.com


$ 1.58 $ 0.02 (1.27 %)    

Friday, 17-May-2024 15:19:18 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.18 $ -0.30 (-0.07 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.91 $ 0.55 (0.25 %)
$ 1.59
$ 1.58
$ 0.00 x 0
$ 0.00 x 0
$ 1.54 - $ 1.58
$ 0.99 - $ 1.94
178,657
na
85.1M
$ 0.95
$ 3.64
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 12-14-2017 09-30-2017 10-Q
28 11-05-2015 09-30-2015 10-Q
29 08-06-2015 06-30-2015 10-Q
30 05-05-2015 03-31-2015 10-Q
31 03-24-2015 12-31-2014 10-K
32 11-04-2014 09-30-2014 10-Q
33 08-07-2014 06-30-2014 10-Q
34 05-06-2014 03-31-2014 10-Q
35 03-25-2014 12-31-2013 10-K
36 11-07-2013 09-30-2013 10-Q
37 08-06-2013 06-30-2013 10-Q
38 05-07-2013 03-31-2013 10-Q
39 03-22-2013 12-31-2012 10-K
40 11-06-2012 09-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-spero-therapeutics-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Sper...
05/16/2024 10:55:06

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...

spero-therapeutics-q1-2024-gaap-eps-024-misses-004-estimate-sales-9267m-miss-21533m-estimate
Spero Therapeutics Q1 2024 GAAP EPS $(0.24...
05/15/2024 20:31:55

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of ...

cantor-fitzgerald-reiterates-overweight-on-spero-therapeutics
Cantor Fitzgerald Reiterates Overweight on...
04/04/2024 13:45:57

Cantor Fitzgerald analyst Louise Chen reiterates Spero Therapeutics (NASDAQ:SPRO) with a Overweight.

hc-wainwright--co-reiterates-buy-on-spero-therapeutics-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Sper...
03/18/2024 11:02:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...

why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Limbach Holdings Shares Are Trading Lo...
03/14/2024 17:38:41

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

why-robinhood-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Robinhood Shares Are Trading Higher By...
03/14/2024 12:05:43

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported Februar...

recap-spero-therapeutics-q4-earnings
Recap: Spero Therapeutics Q4 Earnings
03/13/2024 20:15:18

spero-therapeutics-q4-2023-gaap-eps-096-beats-010-estimate-sales-73524m-beat-18633m-estimate
Spero Therapeutics Q4 2023 GAAP EPS $0.96 ...
03/13/2024 20:12:12

Spero Therapeutics (NASDAQ:SPRO) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $(...

earnings-scheduled-for-march-13-2024
Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

earnings-outlook-for-spero-therapeutics
Earnings Outlook For Spero Therapeutics
03/12/2024 17:01:27

spero-therapeutics-announces-clearance-of-ind-for-spr206-to-treat-mdr-gram-negative-bacterial-infections
Spero Therapeutics Announces Clearance Of ...
02/28/2024 13:08:36

spero-therapeutics-expects-to-provide-phase-2a-topline-proof-of-concept-data-from-spr720-program-co-also-initiated-dosing-in-pivot-po-phase-3-trial-and-is-entitled-to-receive-95m-in-milestones-as-part-of-license-agreement
Spero Therapeutics Expects To Provide Phas...
01/05/2024 13:11:53

spero-therapeutics-announces-first-patient-first-visit-for-phase-3-pivot-po-trial-evaluating-tebipenem-hbr-in-complicated-urinary-tract-infections-spero-is-entitled-to-receive-95m-in-development-milestone-payments-from-gsk-over-2-years
Spero Therapeutics Announces First Patient...
01/02/2024 13:07:41

Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, develop...

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
12/04/2023 14:44:10

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/14/2023 21:31:09

hc-wainwright--co-reiterates-buy-on-spero-therapeutics-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Sper...
11/14/2023 11:31:32

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
11/13/2023 21:31:02

recap-spero-therapeutics-q3-earnings
Recap: Spero Therapeutics Q3 Earnings
11/13/2023 21:20:07

spero-therapeutics-q3-eps-006-misses-003-estimate-sales-2547m-beat-1497m-estimate
Spero Therapeutics Q3 EPS $(0.06) Misses $...
11/13/2023 21:19:23

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of ...

earnings-scheduled-for-november-13-2023
Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION